IL34 and inflammatory bowel disease: Consistent with the proposed role of CSF1R signalling in intestinal macrophage development, CSF1 and the alternative agonist IL34 are both high-expressed in human ileum and colon and further increased in IBD lesions (Zwicker et al. 2015).